520 Phase 2 study ofNivolumab (Anti-PD-1;ONO-4538/BMS-936558)in Japanese patientswith advancedmelanoma: Preliminaryreport Naoya YamazakiYoshio KiyoharaHisashi Uhara2015 год

520 Phase 2 study of Nivolumab (Anti-PD-1; ONO-4538/BMS-936558) in Japanese patients with advanced melanoma: Preliminary report
статья из журнала